No matches

39 search results for: long-term

UEG 2025 | Understanding Type 2 Inflammation in EoE: A Case-Based Discussion
Gastroenterology
UEG 2025 | Understanding Type 2 Inflammation in EoE: A Case-Based Discussion
expert video

Profs. Greuter, Savarino, and Giordano discuss best practices for EoE identification, multidimensional EoE assessment, and transition of care.

View more
Event Thumbnail
Congress
24
October
2025
Congress
ADVENT at EAACI PAAM 2025

Join Sanofi and Regeneron for ​an educational symposium on type 2 inflammation processes underlying pediatric asthma, atopic dermatitis,​ and eosinophilic esophagitis.

View more
Low Disease Activity and Disease Stability: Setting New Goals for COPD Care
Pulmonology
Low Disease Activity and Disease Stability: Setting New Goals for COPD Care
Infographic

This infographic explores the emerging concepts of disease activity, disease stability, and disease control in COPD.

View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: CanadaChange country/region